Cullinan Therapeutics Overview
Cullinan Therapeutics Target Price
Analysts' average 12-month price target for Cullinan Therapeutics is $35.
Get informed when a big investor buys or sells
+ FollowShare Price
$16.87
Average Target Price
$35.33
109.4% upside
109.4% upside3 analysts in the last 4 months
High: $40 | Low: $27
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-14 | BTIG | $40 | 137.1% upside |  |
| 2026-08-17 | UBSDavid Dai | $27 | 60% upside | |
| 2026-07-29 | BTIG | $39 | 131.2% upside | |
| 2026-05-08 | Wedbush | $37 | 119.3% upside | |
| 2026-04-28 | H.C. WainwrightRobert Burns | $30 | 77.8% upside | |
| 2026-03-11 | Wedbush | $36 | 113.4% upside | |
| 2026-03-10 | Stifel NicolausAlex Thompson | $28 | 66% upside | |
| 2026-02-02 | Guggenheim | $30 | 77.8% upside | |
| 2026-01-08 | H.C. Wainwright | $27 | 60% upside | |
| 2026-01-08 | Morgan Stanley | $30 | 77.8% upside | |
| 2025-12-09 | WedbushRobert Driscoll | $34 | 101.5% upside | |
| 2025-11-24 | BTIGJulian Harrison | $38 | 125.3% upside | |
| 2025-11-20 | New Street | $26 | 54.1% upside | |
| 2024-10-24 | UBSDavid Dai | $30 | 77.8% upside | |
| 2024-08-08 | Morgan StanleyJeffrey Hung | $38 | 125.3% upside | |
| 2024-05-16 | H.C. WainwrightEdward White | $28 | 66% upside | |
| 2024-04-17 | BTIGKaveri Pohlman | $30 | 77.8% upside | |
| 2024-04-16 | H.C. WainwrightEdward White | $29 | 71.9% upside | |
| 2023-02-03 | Morgan Stanley | $19 | 12.6% upside | |